NCT00851448View on ClinicalTrials.gov

Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Lung Cancer Patients

NATerminatedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
CachexiaCancer
Interventions
DIETARY_SUPPLEMENT

oral nutritional supplement, food for special medical purposes

2 servings of 200-300 ml per day, treatment period: 16 weeks

Trial Locations (3)

I- 00185

Dipartimento di Medicina Clinica, La Sapienza Università, Rome, Rome

41-709

Indywidualna Specjalistyczna Praktyka lekarska, Ruda Śląska

PL-04-749

Pulmonology Dept. of Miedzylesie Hospital, Warsaw

Sponsors

Lead Sponsor

Fresenius Kabi
All Listed Sponsors
lead

Fresenius Kabi

INDUSTRY